CD276 and cancer: The resistance observed was not attributable to a lack of CD276 expression, as all tested cancer cell types displayed similar CD276 mRNA levels in the Cancer Dependency Map (DepMap) dataset and comparable cell surface protein levels as assessed by flow cytometry (Figures 4D-4F).